Hello, Welcome to Shine Consultant !
Summit & Event Advisor & Insight Research & Analysis
Guest Information
发布时间: 2018 - 05 - 11
点击次数: 0
Positions: Founder and CEO
Company: ForceClouds
个人简介:
William Zhang, founder and CEO of ForceClouds, has also founded a pharmaceutical big data corporation in the early days which was acquired by a AMEX listed company. In 2012, he founded ForceClouds and then acquired supports from top VCs such as Fidelity, and reached a strategic cooperation with American Ivy College Cornell University School of Medicine and established a medical artificial intelligence laboratory, developed a world-leading new drug discovery engine based on artificial intelligence technology. At present, ForceClouds serves customers include AstraZeneca, Bayer, Eisai Pharmaceutical, Takeda Pharmaceutical and CR Double-Crane, which have become a leader in cloud solutions in the life sciences.
发布时间: 2018 - 05 - 11
点击次数: 0
Positions: Partner
Company: GlobalLaw’s Shanghai Office
个人简介:
Alan Zhou is a partner at Global Law’s Shanghai Office. His practice is focused in the areas of mergers & acquisitions, private equity/venture capital, general corporate, and regulatory compliance. Mr. Zhou has represented many multinational corporations, reputable Chinese state owned and private corporations, and private equity/venture capital funds in a wide range of industries.  As an expert on legal issues surrounding M&A, compliance and anti-corruption and taxes of foreign invested enterprises in China, Mr. Zhou has provided several well-known multinational companies with legal opinions on some of the most challenging aspects of  foreign investment in China. Mr. Zhou has a particularly strong background in the Pharmaceutical and Healthcare, and TMT industrial sectors. As the leading partner at Pharmaceutical and Healthcare practice group at Global, Mr. Zhou is praised for his "broad knowledge of the law, deep understanding of the pharmaceutical industry and  strong  communication  skills."  –Chambers  and Partners . Mr. Zhou has routinely represented such multinational corporations as AstraZenca, Novartis, MSD, GSK, Sanofi, Schlumberger, Boehringer Ingelheim, Siemens, Aon, Bureau Veritas, Tosoh, Societe Generale Bank and SK Telecom. Mr. Zhou not only worked for reputable Chinese private companies such as Focus Media, Acorn International, Hisoar Pharmaceutical, Tianyuan Biopharm, and Yonjin Group, he also advised PRC state owned companies such as Shanghai Dasheng, Shanghai Industrial and Shanghai Airport Authority.  In the area of PE/VC, Mr. Zhou has acted for CBRE Investors, Colony Capital, Navis Capital, Lightspeed Ventures, Qiming Ventures, DT Capital, NEA, New Alliance Capital, Warden International, WINS and other international and local investment funds. Mr. Zhou has been  worked with Boehringer Ingelheim China as the general counsel in China over nine years and is responsible for various legal matters including general corporate, acquisitions and joint venture formation, regulatory compliance, intellectual property and corporate restructure.
发布时间: 2018 - 05 - 09
点击次数: 0
Positions: PhD, Senior Director & Head, Statistical Innovation & Consultation
Company: Takeda Pharmaceutical Company
个人简介:
Dr. Ray Liu is the Sr. Director and Head of Statistical Innovation and Consultation group at Takeda Pharmaceutical Company with responsibility to develop novel statistical methodology, and provide statistical consultation and project support to various functional areas in R&D, including Discovery, CMC, Translational Research, and Outcome Research. Ray is an active contributor in the statistical community. He was the conference chair of Midwest Biopharmaceutical Statistics Workshop for years 2015 and 2016, and has served at the organizing committee and as session chairs for various conferences, including NCB, ICSA and JSM meetings. He is the author of more than 30 statistical and scientific manuscripts and book chapters, and is the member of ASA, PSTC Stats working group, IQ consortium, and NCBLF. He is the editor of the Springer book “Statistical Applications from Clinical Trials and Personalized Medicine to Finance and Business Analytics”. Dr. Ray Liu received his bachelor and master degrees from National Taiwan University and PhD degree from Columbia University. His current research interests are big data, text mining and joint analysis of hi-dimensional data.
发布时间: 2018 - 04 - 25
点击次数: 0
Positions: President & CEO
Company: AbMax Biotechnology Co, LTD.
个人简介:
AbMax Biotechnology Co, LTD.